PACKAGE LABEL.PRINCIPAL DISPLAY PANEL.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL. NDC 70771-1777-3Norelgestromin and Ethinyl Estradiol Transdermal System 150/35 mcg per day This product is intended to prevent pregnancy. It does not protect against HIV infection (AIDS) and other sexually transmitted diseases. For Transdermal Use Only Contents: Transdermal SystemsRx only Each 15.75 cm2 system contains 4.678 mg norelgestromin, USP and 0.53 mg ethinyl estradiol, USP. The inactive components are polyisobutylene/polybutene adhesive, crospovidone, lauryl lactate, non-woven polyester fabric, polyester backing film laminate and polyester release liner.See patient instructions. Apply immediately upon removal from pouch. Each transdermal system is intended to be worn days as prescribed.Package not child-resistant. Keep out of reach of children. Do not store unpouched. Store at 20 to 25C (68 to 77F). [See USP Controlled Room Temperature.] Manufactured by:Zydus Lifesciences Ltd.Ahmedabad, IndiaDistributed by:Zydus Pharmaceuticals (USA) Inc.Pennington, NJ 08534. carton.